prism barcoding method (Broad Institute Inc)
Structured Review

Prism Barcoding Method, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/barcoding+methods/prism+barcoding+method/pmc08728279-1-29-34
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis"
Article Title: PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
Journal: Nucleic Acids Research
doi: 10.1093/nar/gkab1084
Figure Legend Snippet: Details of new and updated datasets in PharmacoDB 2.0
Techniques Used: Microarray, Colorimetric Assay, Mutagenesis, Luminex, Generated
Related Articles
RNA Sequencing:Article Title: PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis Article Snippet: US National Cancer Institute 60 anticancer drug screen ( NCI-60 ) , NCI-60 dataset consists of molecular profiles as well as the dose–response data from screening small molecules including approved and investigational drug compounds , RNA-seq isoforms RNA-seq composite Microarray MicroRNA , 162 , 54774 , 15 , Sulforhodamine B colorimetry , https://wiki.nci.nih.gov/download/attachments/147193864/DOSERESP.zip?version=1&modificationDate=1622830743000&api=v2 , https://orcestra.ca/pset/10.5281/zenodo.5570629. .. The PRISM Repurposing dataset ( PRISM ) , The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the Microarray:Article Title: PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis Article Snippet: US National Cancer Institute 60 anticancer drug screen ( NCI-60 ) , NCI-60 dataset consists of molecular profiles as well as the dose–response data from screening small molecules including approved and investigational drug compounds , RNA-seq isoforms RNA-seq composite Microarray MicroRNA , 162 , 54774 , 15 , Sulforhodamine B colorimetry , https://wiki.nci.nih.gov/download/attachments/147193864/DOSERESP.zip?version=1&modificationDate=1622830743000&api=v2 , https://orcestra.ca/pset/10.5281/zenodo.5570629. .. The PRISM Repurposing dataset ( PRISM ) , The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the Mutagenesis:Article Title: PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis Article Snippet: US National Cancer Institute 60 anticancer drug screen ( NCI-60 ) , NCI-60 dataset consists of molecular profiles as well as the dose–response data from screening small molecules including approved and investigational drug compounds , RNA-seq isoforms RNA-seq composite Microarray MicroRNA , 162 , 54774 , 15 , Sulforhodamine B colorimetry , https://wiki.nci.nih.gov/download/attachments/147193864/DOSERESP.zip?version=1&modificationDate=1622830743000&api=v2 , https://orcestra.ca/pset/10.5281/zenodo.5570629. .. The PRISM Repurposing dataset ( PRISM ) , The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the Article Title: Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny Article Snippet: .. Dataset Description Collected OmicsData # Cell lines # Drugs Collected Drugs Sensitivity Metrics Data Sources Cancer Therapeutic Response Portal (CTRP1) CTRP project was developed by researchers at the Center for the Science of Therapeutics at the Broad Institute and is sponsored in part by the NCI's Cancer Target Discovery and Development Network. mRNA expression, Gene fusion, Methylation, Mutation, CNV, Protein 9 341 AUC https://portals.broadinstitute.org/ctrp.v1/ Cancer Therapeutic Response Portal (CTRP2) 71 481 AUC https://portals.broadinstitute.org/ctrp.v2.1/ The PRISM Repurposing dataset (PRISM) The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the Clinical Proteomics:Article Title: Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny Article Snippet: .. Dataset Description Collected OmicsData # Cell lines # Drugs Collected Drugs Sensitivity Metrics Data Sources Cancer Therapeutic Response Portal (CTRP1) CTRP project was developed by researchers at the Center for the Science of Therapeutics at the Broad Institute and is sponsored in part by the NCI's Cancer Target Discovery and Development Network. mRNA expression, Gene fusion, Methylation, Mutation, CNV, Protein 9 341 AUC https://portals.broadinstitute.org/ctrp.v1/ Cancer Therapeutic Response Portal (CTRP2) 71 481 AUC https://portals.broadinstitute.org/ctrp.v2.1/ The PRISM Repurposing dataset (PRISM) The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the Expressing:Article Title: Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny Article Snippet: .. Dataset Description Collected OmicsData # Cell lines # Drugs Collected Drugs Sensitivity Metrics Data Sources Cancer Therapeutic Response Portal (CTRP1) CTRP project was developed by researchers at the Center for the Science of Therapeutics at the Broad Institute and is sponsored in part by the NCI's Cancer Target Discovery and Development Network. mRNA expression, Gene fusion, Methylation, Mutation, CNV, Protein 9 341 AUC https://portals.broadinstitute.org/ctrp.v1/ Cancer Therapeutic Response Portal (CTRP2) 71 481 AUC https://portals.broadinstitute.org/ctrp.v2.1/ The PRISM Repurposing dataset (PRISM) The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the Methylation:Article Title: Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny Article Snippet: .. Dataset Description Collected OmicsData # Cell lines # Drugs Collected Drugs Sensitivity Metrics Data Sources Cancer Therapeutic Response Portal (CTRP1) CTRP project was developed by researchers at the Center for the Science of Therapeutics at the Broad Institute and is sponsored in part by the NCI's Cancer Target Discovery and Development Network. mRNA expression, Gene fusion, Methylation, Mutation, CNV, Protein 9 341 AUC https://portals.broadinstitute.org/ctrp.v1/ Cancer Therapeutic Response Portal (CTRP2) 71 481 AUC https://portals.broadinstitute.org/ctrp.v2.1/ The PRISM Repurposing dataset (PRISM) The PRISM dataset consists of dose–response data from assessing the anti-cancer effects of non-oncology drugs on human cancer cell-lines using the |